← Back to home

PATIENTS WITH HER2-POSITIVE BREAST CANCER (BC) SUITABLE FOR NEOADJUVANT THERAPY

Clinical trials for PATIENTS WITH HER2-POSITIVE BREAST CANCER (BC) SUITABLE FOR NEOADJUVANT THERAPY explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH HER2-POSITIVE BREAST CANCER (BC) SUITABLE FOR NEOADJUVANT THERAPY trials appear

Sign up with your email to follow new studies for PATIENTS WITH HER2-POSITIVE BREAST CANCER (BC) SUITABLE FOR NEOADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Breakthrough trial aims to customize breast cancer treatment while cutting chemo side effects

Disease control Not yet recruiting

This large study aims to improve treatment for HER2-positive breast cancer by personalizing therapy based on each patient's response. Researchers will test whether adjusting treatment intensity—increasing it for some patients while decreasing it for others—can lead to better outc…

Matched conditions: PATIENTS WITH HER2-POSITIVE BREAST CANCER (BC) SUITABLE FOR NEOADJUVANT THERAPY

Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PATIENTS WITH HER2-POSITIVE BREAST CANCER (BC) SUITABLE FOR NEOADJUVANT THERAPY

Get alerted when new PATIENTS WITH HER2-POSITIVE BREAST CANCER (BC) SUITABLE FOR NEOADJUVANT THERAPY trials appear

Breakthrough trial aims to customize breast cancer treatment while cutting chemo side effects